Feed PEN
PE

Penumbra PEN · NYSE

$325.11 +0.48% (+$1.55)

Market cap
$12.8B
Enterprise value
$12.8B
P/E
79.7x
Forward P/E
67.1x
PEG
0.1x
P/S
8.5x
P/FCF
59.3x
EV/EBITDA
57.6x
ROIC
8.4%
Gross margin
67.8%
Net margin
10.7%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
0.0x
Beta
0.70
Free float
97.2%

About the company

Solventum Corporation is an American technology company that focuses on developing innovative solutions in the fields of chemistry and pharmaceuticals. It specializes in providing services related to research, development, and commercialization of chemical and pharmaceutical products. Solventum Corporation collaborates with pharmaceutical and biotechnology companies to optimize manufacturing processes and develop new active ingredients. The company's goal is to improve the efficiency and safety of chemical processes, with a focus on sustainability and technological innovations.

Sector

Healthcare

Industry

Medical - Devices

CEO

Adam Elsesser

Employees

4,700

Headquarters

Alameda

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.